<p>Apyx Medical Corporation（纳斯达克代码：APYX - 获取免费报告）周一的盘中交易中股价下跌了 1.8%。该公司的股价最低曾达到 3.73 美元，最后交易价为 3.79 美元。在盘中交易中，共成交 38,540 股，较平均交易量 115,008 股下降了 66%。该股票此前收盘价为 3.86 美元。</p>
<h2>分析师评级变动</h2>
<p>多位股票分析师最近对 APYX 股票发表了评论。Citizens Jmp 将 Apyx Medical 的评级从 “市场表现” 上调至 “跑赢大盘”，并在 11 月 12 日的研究报告中设定了 8.00 美元的目标价。Weiss Ratings 在 10 月 8 日的研究报告中重申了对 Apyx Medical 的 “卖出（e+）” 评级。Roth Capital 在周一的研究报告中开始覆盖 Apyx Medical 股票，给予 “买入” 评级，并设定 6.00 美元的目标价。最后，Wall Street Zen 在 11 月 22 日的研究报告中将 Apyx Medical 的评级上调至 “持有”。两位股票研究分析师给予该股票 “买入” 评级，一位给予 “卖出” 评级。根据 MarketBeat 的数据，Apyx Medical 目前的共识评级为 “持有”，共识目标价为 7.00 美元。</p>
<p><strong>获取我们关于 Apyx Medical 的最新股票报告</strong></p>
<h2>Apyx Medical 股价下跌 1.8%</h2>
<p>该公司的 50 日简单移动平均线为 3.57 美元，200 日简单移动平均线为 2.59 美元。公司的债务与股本比率为 5.69，流动比率为 4.44，速动比率为 3.61。该公司的市值为 1.4493 亿美元，市盈率为-10.53，贝塔值为 1.48。</p>
<p>Apyx Medical（纳斯达克代码：APYX - 获取免费报告）最近在 11 月 6 日发布了季度财报。该公司报告每股收益（EPS）为-0.05 美元，超出市场共识预期的-0.10 美元，超出幅度为 0.05 美元。Apyx Medical 的股本回报率为-151.01%，净利润率为-30.35%。该公司季度收入为 1288 万美元，而分析师预期为 1200 万美元。股票分析师预计 Apyx Medical Corporation 在本年度将发布-0.68 美元的每股收益。</p>
<h2>机构投资者对 Apyx Medical 的看法</h2>
<p>对冲基金最近对该股票的持仓进行了调整。Citadel Advisors LLC 在第三季度新建了约 28,000 美元的 Apyx Medical 持仓。Fisher Asset Management LLC 在第二季度购买了价值 34,000 美元的 Apyx Medical 新股份。Caprock Group LLC 在第三季度新建了价值 40,000 美元的 Apyx Medical 持仓。Osaic Holdings Inc.在第二季度购买了价值 50,000 美元的 Apyx Medical 新股份。最后，Franklin Resources Inc.在第三季度新建了价值 59,000 美元的 Apyx Medical 持仓。目前，55.33% 的股票由机构投资者和对冲基金持有。</p>
<h2>关于 Apyx Medical</h2>
<p>（获取免费报告）</p>
<p>Apyx Medical Corporation 是一家能源技术公司，专注于在美国和国际上设计、开发和制造医疗设备。该公司通过两个部门运营：先进能源和原始设备制造（OEM）。它提供氦等离子发生器，用于在开放和微创手术过程中切割、凝固和消融软组织。</p>
<h2>精选文章</h2>
<ul>
<li>我们更看好的五只股票，胜过 Apyx Medical</li>
<li>交易暂停的解释</li>
<li>ServiceNow 的 70 亿美元赌注：恐慌还是机会？</li>
<li>10 只最佳航空公司股票推荐</li>
<li>戴尔和惠普正在涨价——投资者应注意</li>
<li>什么是股息？购买最佳股息股票</li>
<li>为什么 DLocal 是 2026 年值得关注的顶级新兴市场金融科技股票</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Apyx Medical 吗？</h2>
<p>在考虑 Apyx Medical 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐，现在购买，以便在更广泛的市场注意到之前……而 Apyx Medical 并不在名单上。</p>
<p>虽然 Apyx Medical 目前在分析师中获得 “持有” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

APYX

<p>Apyx Medical 的股票在午盘交易中下跌了 1.8%，交易量显著减少。分析师的评级意见不一：Citizens Jmp 将评级上调至 “跑赢大盘”，目标价为 8 美元；Weiss Ratings 维持 “卖出” 评级；Roth Capital 给予 “买入” 评级，目标价为 6 美元；Wall Street Zen 则上调至 “持有”。共识评级为 “持有”，目标价为 7 美元。机构投资者最近已调整了对该股票的持仓</p>

<p>Apyx Medical Corporation (NASDAQ:APYX - Get Free Report)'s share price fell 1.8% during mid-day trading on Monday . The company traded as low as $3.73 and last traded at $3.79. 38,540 shares traded hands during mid-day trading, a decline of 66% from the average session volume of 115,008 shares. The stock had previously closed at $3.86.</p>
<div class="lb-trans"><p>Apyx Medical Corporation（纳斯达克代码：APYX - 获取免费报告）周一的盘中交易中股价下跌了 1.8%。该公司的股价最低曾达到 3.73 美元，最后交易价为 3.79 美元。在盘中交易中，共成交 38,540 股，较平均交易量 115,008 股下降了 66%。该股票此前收盘价为 3.86 美元。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><p>A number of equities analysts recently commented on APYX shares. Citizens Jmp raised shares of Apyx Medical from a &#34;market perform&#34; rating to an &#34;outperform&#34; rating and set a $8.00 price target on the stock in a research report on Wednesday, November 12th. Weiss Ratings restated a &#34;sell (e+)&#34; rating on shares of Apyx Medical in a research report on Wednesday, October 8th. Roth Capital started coverage on shares of Apyx Medical in a research report on Monday. They issued a &#34;buy&#34; rating and a $6.00 price target for the company. Finally, Wall Street Zen upgraded Apyx Medical to a &#34;hold&#34; rating in a research note on Saturday, November 22nd. Two equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Apyx Medical presently has a consensus rating of &#34;Hold&#34; and a consensus price target of $7.00.</p>
<div class="lb-trans"><p>多位股票分析师最近对 APYX 股票发表了评论。Citizens Jmp 将 Apyx Medical 的评级从 “市场表现” 上调至 “跑赢大盘”，并在 11 月 12 日的研究报告中设定了 8.00 美元的目标价。Weiss Ratings 在 10 月 8 日的研究报告中重申了对 Apyx Medical 的 “卖出（e+）” 评级。Roth Capital 在周一的研究报告中开始覆盖 Apyx Medical 股票，给予 “买入” 评级，并设定 6.00 美元的目标价。最后，Wall Street Zen 在 11 月 22 日的研究报告中将 Apyx Medical 的评级上调至 “持有”。两位股票研究分析师给予该股票 “买入” 评级，一位给予 “卖出” 评级。根据 MarketBeat 的数据，Apyx Medical 目前的共识评级为 “持有”，共识目标价为 7.00 美元。</p>
</div><p><strong>Get Our Latest Stock Report on Apyx Medical</strong></p>
<div class="lb-trans"><p><strong>获取我们关于 Apyx Medical 的最新股票报告</strong></p>
</div><h2>Apyx Medical Trading Down 1.8%</h2>
<div class="lb-trans"><h2>Apyx Medical 股价下跌 1.8%</h2>
</div><p>The firm's 50-day simple moving average is $3.57 and its 200 day simple moving average is $2.59. The company has a debt-to-equity ratio of 5.69, a current ratio of 4.44 and a quick ratio of 3.61. The firm has a market capitalization of $144.93 million, a price-to-earnings ratio of -10.53 and a beta of 1.48.</p>
<div class="lb-trans"><p>该公司的 50 日简单移动平均线为 3.57 美元，200 日简单移动平均线为 2.59 美元。公司的债务与股本比率为 5.69，流动比率为 4.44，速动比率为 3.61。该公司的市值为 1.4493 亿美元，市盈率为-10.53，贝塔值为 1.48。</p>
</div><p>Apyx Medical (NASDAQ:APYX - Get Free Report) last issued its quarterly earnings results on Thursday, November 6th. The company reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.10) by $0.05. Apyx Medical had a negative return on equity of 151.01% and a negative net margin of 30.35%.The company had revenue of $12.88 million for the quarter, compared to analyst estimates of $12.00 million. Equities analysts expect that Apyx Medical Corporation will post -0.68 earnings per share for the current year.</p>
<div class="lb-trans"><p>Apyx Medical（纳斯达克代码：APYX - 获取免费报告）最近在 11 月 6 日发布了季度财报。该公司报告每股收益（EPS）为-0.05 美元，超出市场共识预期的-0.10 美元，超出幅度为 0.05 美元。Apyx Medical 的股本回报率为-151.01%，净利润率为-30.35%。该公司季度收入为 1288 万美元，而分析师预期为 1200 万美元。股票分析师预计 Apyx Medical Corporation 在本年度将发布-0.68 美元的每股收益。</p>
</div><h2>Institutional Investors Weigh In On Apyx Medical</h2>
<div class="lb-trans"><h2>机构投资者对 Apyx Medical 的看法</h2>
</div><p>Hedge funds have recently made changes to their positions in the stock. Citadel Advisors LLC acquired a new position in Apyx Medical during the 3rd quarter worth approximately $28,000. Fisher Asset Management LLC bought a new stake in shares of Apyx Medical during the second quarter worth $34,000. Caprock Group LLC acquired a new position in shares of Apyx Medical during the third quarter worth $40,000. Osaic Holdings Inc. bought a new position in shares of Apyx Medical in the 2nd quarter valued at $50,000. Finally, Franklin Resources Inc. acquired a new stake in shares of Apyx Medical during the 3rd quarter valued at $59,000. 55.33% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>对冲基金最近对该股票的持仓进行了调整。Citadel Advisors LLC 在第三季度新建了约 28,000 美元的 Apyx Medical 持仓。Fisher Asset Management LLC 在第二季度购买了价值 34,000 美元的 Apyx Medical 新股份。Caprock Group LLC 在第三季度新建了价值 40,000 美元的 Apyx Medical 持仓。Osaic Holdings Inc.在第二季度购买了价值 50,000 美元的 Apyx Medical 新股份。最后，Franklin Resources Inc.在第三季度新建了价值 59,000 美元的 Apyx Medical 持仓。目前，55.33% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>About Apyx Medical</h2>
<div class="lb-trans"><h2>关于 Apyx Medical</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.</p>
<div class="lb-trans"><p>Apyx Medical Corporation 是一家能源技术公司，专注于在美国和国际上设计、开发和制造医疗设备。该公司通过两个部门运营：先进能源和原始设备制造（OEM）。它提供氦等离子发生器，用于在开放和微创手术过程中切割、凝固和消融软组织。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Apyx Medical</li>
<li>Trading Halts Explained</li>
<li>ServiceNow’s $7 Billion Gamble: Panic or Opportunity?</li>
<li>10 Best Airline Stocks to Buy</li>
<li>Dell and HP Are Raising Prices—And Investors Should Take Note</li>
<li>What Are Dividends? Buy the Best Dividend Stocks</li>
<li>Why DLocal Is the Top Emerging Market Fintech Stock to Watch for 2026</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，胜过 Apyx Medical</li>
<li>交易暂停的解释</li>
<li>ServiceNow 的 70 亿美元赌注：恐慌还是机会？</li>
<li>10 只最佳航空公司股票推荐</li>
<li>戴尔和惠普正在涨价——投资者应注意</li>
<li>什么是股息？购买最佳股息股票</li>
<li>为什么 DLocal 是 2026 年值得关注的顶级新兴市场金融科技股票</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Apyx Medical Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Apyx Medical 吗？</h2>
</div><p>Before you consider Apyx Medical, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Apyx Medical 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Apyx Medical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐，现在购买，以便在更广泛的市场注意到之前……而 Apyx Medical 并不在名单上。</p>
</div><p>While Apyx Medical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Apyx Medical 目前在分析师中获得 “持有” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Apyx Medical（NASDAQ:APYX）股价下跌 1.8% - 以下是原因